Nasdaq Top Companies List by Market Cap as of January 2024
Nasdaq Top Companies List by Market Cap as of Jan-05-2024, Nasdaq Biggest 500 Companies List by Market Cap, Nasdaq Largest 500 Companies List by market cap as of Jan-05-2024.-
World Rank (Jan-05-2024)10,644Market Cap (Jan-05-2024)0.691 Billion USDWorld Rank (Jul-30-2023)10,555Market Cap (Jul-30-2023)0.716 Billion USDWorld Rank (Dec-25-2022)10,047Market Cap (Dec-25-2022)0.740 Billion USDWorld Rank (Jan-07-2022)11,986Market Cap (Jan-07-2022)0.64 Billion USDAnnual Revenue in USD244 Million USDAnnual Net Income in USD67 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany Website
-
Boingo Wireless
-
Novavax
World Rank (Jan-05-2024)11,359Market Cap (Jan-05-2024)0.613 Billion USDWorld Rank (Jul-30-2023)10,617Market Cap (Jul-30-2023)0.708 Billion USDWorld Rank (Dec-25-2022)9,445Market Cap (Dec-25-2022)0.821 Billion USDWorld Rank (Jan-07-2022)1,955Market Cap (Jan-07-2022)9.58 Billion USDAnnual Revenue in USD1,598 Million USDAnnual Net Income in USD-657 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileNovavax is a Late Stage Biotechnology company that promotes improved global health through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. The company annual revenue is 157.0 million USD and 375 employees as on 2020. The headquarters is in USA.
-
Editas Medicine
World Rank (Jan-05-2024)9,928Market Cap (Jan-05-2024)0.779 Billion USDWorld Rank (Jul-30-2023)10,632Market Cap (Jul-30-2023)0.707 Billion USDWorld Rank (Dec-25-2022)11,186Market Cap (Dec-25-2022)0.608 Billion USDWorld Rank (Jan-07-2022)6,883Market Cap (Jan-07-2022)1.72 Billion USDAnnual Revenue in USD20 Million USDAnnual Net Income in USD-220 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileEditas Medicine is a Biotechnology company. It is a genome editing systems into a robust pipeline of medicines for people living with serious diseases around the world. The company discover, develop, manufacture, and commercialize transformative, durable and precise genomic medicines for a broad class of diseases. The headquarters is in USA.Company Website -
Orthofix Medical
World Rank (Jan-05-2024)12,889Market Cap (Jan-05-2024)0.478 Billion USDWorld Rank (Jul-30-2023)10,633Market Cap (Jul-30-2023)0.707 Billion USDWorld Rank (Dec-25-2022)14,094Market Cap (Dec-25-2022)0.387 Billion USDWorld Rank (Jan-07-2022)12,189Market Cap (Jan-07-2022)0.61 Billion USDAnnual Revenue in USD460 Million USDAnnual Net Income in USD-20 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileOrthofix Medical is a diversified, global medical device company focused on improving patients lives by providing superior reconstruction and regenerative orthopedic and spine solutions to physicians worldwide. The company products are distributed in more than 70 countries around the world via Orthofix sales representatives, stocking distributors and subsidiaries. It has more than 1000 employees around the world are dedicated to the development, manufacturing and distribution of orthopedic and spine products and regenerative tissue forms. The headquarters is in USA.Company Website -
Clearfield
World Rank (Jan-05-2024)13,452Market Cap (Jan-05-2024)0.436 Billion USDWorld Rank (Jul-30-2023)10,648Market Cap (Jul-30-2023)0.704 Billion USDWorld Rank (Dec-25-2022)6,690Market Cap (Dec-25-2022)1.451 Billion USDWorld Rank (Jan-07-2022)9,524Market Cap (Jan-07-2022)0.99 Billion USDAnnual Revenue in USD270 Million USDAnnual Net Income in USD49 Million USDAnnual Results for Period EndingSep-2022 ending yearCompany ProfileClearfield designs, manufactures and distributes fiber optic management products company helping service providers reduce the high costs associated with deploying, managing, protecting and scaling a fiber optic network to deliver the mobile, residential and business services customers want. the company annual revenue is 110.1 million USD and 240 employees as on 2020. The headquarters is in USA.Company WebsiteWikipedia -
Cronos Group
World Rank (Jan-05-2024)9,582Market Cap (Jan-05-2024)0.831 Billion USDWorld Rank (Jul-30-2023)10,676Market Cap (Jul-30-2023)0.701 Billion USDWorld Rank (Dec-25-2022)8,560Market Cap (Dec-25-2022)0.963 Billion USDWorld Rank (Jan-07-2022)7,559Market Cap (Jan-07-2022)1.45 Billion USDAnnual Revenue in USD57 Million USDAnnual Net Income in USD-305 Million USDAnnual Results for Period EndingDec-2021 ending yearCompany ProfileCannabis company with headquarters is in Canada.Company Website -
Stemline Therapeutics
World Rank (Jan-05-2024)10,696World Rank (Jul-30-2023)10,696World Rank (Dec-25-2022)10,696World Rank (Jan-07-2022)10,696Company ProfileMenarini Group Completes acquired Stemline Therapeutics in June 2020.
Stemline Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics. ELZONRIS (tagraxofusp), a targeted therapy directed to CD123, is FDA-approved and commercially available in the U.S. for the treatment of adult and pediatric patients, two years and older, with blastic plasmacytoid dendritic cell neoplasm (BPDCN).
-
Community Trust Bancorp
World Rank (Jan-05-2024)9,983Market Cap (Jan-05-2024)0.771 Billion USDWorld Rank (Jul-30-2023)10,711Market Cap (Jul-30-2023)0.697 Billion USDWorld Rank (Dec-25-2022)9,473Market Cap (Dec-25-2022)0.819 Billion USDWorld Rank (Jan-07-2022)10,537Market Cap (Jan-07-2022)0.82 Billion USDAnnual Revenue in USD227 Million USDAnnual Net Income in USD82 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany Website -
BlackRock TCP Capital
World Rank (Jan-05-2024)10,690Market Cap (Jan-05-2024)0.687 Billion USDWorld Rank (Jul-30-2023)10,720Market Cap (Jul-30-2023)0.696 Billion USDWorld Rank (Dec-25-2022)9,965Market Cap (Dec-25-2022)0.751 Billion USDWorld Rank (Jan-07-2022)10,745Market Cap (Jan-07-2022)0.79 Billion USDAnnual Revenue in USD3 Million USDAnnual Net Income in USD-9 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileBlackRock TCP Capital is an Externally Managed Specialty Finance company focused on middle market lending. The company annual revenue is 33.1 million USD, annual operating income is 22.1 million USD and annual net income is 46.5 million USD. The headquarters is in USA.Company Website